Home / Inspections / 1133055

FDA Inspection 1133055 — Biogen, Inc.

Biogen, Inc. — FEI 1220951

The FDA completed an inspection of Biogen, Inc. on November 10, 2020 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 10, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1190494 (NAI Fri Nov 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180550 (NAI Fri Sep 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1130379 (NAI Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046583 (NAI Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008333 (VAI Thu Apr 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources